Wednesday, October 21, 2015
Valeant shares plunge on short-seller scrutiny of pharmacy revenue
NEW YORK (Reuters) - Valeant Pharmaceuticals International Inc's stock plunged as much as 40 percent on Wednesday after an influential short-seller accused the company of using specialty pharmacies to inflate its revenue, an allegation that the drugmaker denied.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment